{"id":1126070,"date":"2024-06-15T19:52:06","date_gmt":"2024-06-15T23:52:06","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/the-7-best-robotics-stocks-to-buy-in-june-2024-investorplace\/"},"modified":"2024-06-15T19:52:06","modified_gmt":"2024-06-15T23:52:06","slug":"the-7-best-robotics-stocks-to-buy-in-june-2024-investorplace","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/robotics\/the-7-best-robotics-stocks-to-buy-in-june-2024-investorplace\/","title":{"rendered":"The 7 Best Robotics Stocks to Buy in June 2024 &#8211; InvestorPlace"},"content":{"rendered":"<p><p>    As the broader indices like the Nasdaq    continue their upward trajectory, now is a compelling time to    consider investing in robotics stocks. The robotics industry,    buoyed by rapid technological advancements and increasing    demand across sectors such as manufacturing, logistics and    healthcare, presents a wealth of opportunities for savvy    investors looking for the best robotics stocks to buy.  <\/p>\n<p>    Investing in these robotics stocks today could yield    substantial gains as the industry is projected to grow    significantly. The service robotics market, valued at $41.5    billion in 2023, is expected to soar to $84.8 billion by 2028,    expanding at an annual growth rate of over 20%. By securing    positions in these companies now, investors can lock in    potential capital appreciation before the market peaks.  <\/p>\n<p>    Here are seven of the best robotics stocks to buy in June 2024.    These companies have immense growth potential and the    capability to become market leaders in the burgeoning field of    robotics. With the right investments, these stocks could become    millionaires for forward-thinking investors.  <\/p>\n<p>      Source: Sundry Photography \/ Shutterstock.com    <\/p>\n<p>    Intuitive Surgical (NASDAQ:ISRG)    known for its da Vinci Surgical System, which has facilitated    over 13 million surgical procedures. It is expected to continue    expanding its installed base and clinical applications.  <\/p>\n<p>    In 2023, ISRG placed 1,370 da Vinci surgical systems, up    from 1,264 in 2022. This included a notable increase in systems    placed under operating lease arrangements. The company saw its    revenue grow to $7.12 billion, a 14.49% increase from $6.22    billion in 2022.  <\/p>\n<p>    Analysts have set a 12-month price target for ISRG stock at an    average of $403.67, ranging between $314 and $500. The    consensus rating is a moderate buy based on 14 buy ratings and    four hold ratings.  <\/p>\n<p>    For Q1 2024, ISRG reported earnings per share (EPS) of $1.50, surpassing    the consensus estimate of $1.40. The revenue for this quarter    was $1.89 billion, beating the estimated $1.87 billion and    marking an 11.5% year-over-year increase.  <\/p>\n<p>      Source: Pavel Kapysh \/ Shutterstock    <\/p>\n<p>    Cognex (NASDAQ:CGNX)    specializes in machine vision systems used in manufacturing    automation. It has strong financials and recently integrated AI    and advanced analytics.  <\/p>\n<p>    In Q1 2024, Cognex posted revenue of $210.8 million, a 5%    increase year over year, surpassing the analyst estimate of    $200.42 million. The companys net income for the quarter was    $12 million, or $0.11 per share, beating expectations of $0.08    per share. This quarters performance was bolstered by strong    contributions from its machine vision systems and the    integration of advanced AI and analytics.  <\/p>\n<p>    Looking ahead to 2024, Cognex has provided optimistic guidance,    expecting revenue for Q2 2024 to be between $230 million and    $245 million. This projected increase reflects typical seasonal    trends and a recovery in consumer electronics revenue.  <\/p>\n<p>    Analysts have set a 12-month price target for CGNX stock at an    average of $49.15, ranging between $41 and $60. This suggests a    potential upside of approximately 6.2% from the current price.  <\/p>\n<p>      Source: T. Schneider \/ Shutterstock.com    <\/p>\n<p>    Symbotic (NASDAQ:SYM)    specializes in warehouse automation with AI-embedded software.    The company has shown strong financial growth and is working on    diversifying its customer base.  <\/p>\n<p>    For the first quarter of fiscal 2024, Symbotic reported revenue of $369 million, a    significant increase from $206 million in the same period in    2023. Despite this growth, the company posted a net loss of $13    million, an improvement from the previous year. In the second    quarter of fiscal 2024, Symbotics revenue rose to $424    million, although it reported a net loss of $41 million.  <\/p>\n<p>    Looking forward, Symbotic has provided optimistic guidance for    2024. The company expects to continue its revenue growth trend,    driven by its AI-enabled robotics technology for supply chains.    Analysts predict the companys stock price could reach an average of    $55.69 within the next year, suggesting a possible upside of    48.5% from the current price.  <\/p>\n<p>      Source: Michael Vi \/ Shutterstock.com    <\/p>\n<p>    Teradyne (NASDAQ:TER)    is a leader in industrial automation and robotics testing. Its    products are crucial for ensuring the quality and functionality    of advanced robotic systems.  <\/p>\n<p>    For the first quarter of 2024, Teradyne reported revenue of $600 million, exceeding    analysts expectations of $566.31 million. The company achieved    a GAAP net income of $64.2 million, or $0.40 per diluted share.    Teradynes Q1 2024 non-GAAP earnings per share were $0.51,    surpassing the guidance range of $0.38 to $0.48.  <\/p>\n<p>    Teradyne has guided Q2 2024, projecting revenue between $665    million and $725 million, with GAAP net income per diluted    share expected to range from $0.45 to $0.65.  <\/p>\n<p>    The company continues to focus on expanding its market presence    in industrial automation and robotics testing, which are    crucial for ensuring the quality and functionality of advanced    robotic systems.  <\/p>\n<p>      Source: Michael Vi\/ShutterStock.com    <\/p>\n<p>    Zebra Technologies (NASDAQ:ZBRA)    provides solutions that enhance the efficiency of robotic    systems in logistics and supply chain operations. These    solutions offer critical tools for inventory and asset    management.  <\/p>\n<p>    In the first quarter of 2024, Zebra Technologies reported net sales of $1.175 billion,    reflecting a 16.4% year-over-year decline. Net income for Q1    2024 was $115 million, with net income per diluted share at    $2.23. Despite the decrease in sales, the company managed to    control costs, which helped mitigate some of the impact on    profitability.  <\/p>\n<p>    Looking ahead, Zebras outlook for 2024 shows signs of modest    recovery. The company has implemented expanded cost reduction    plans, expected to drive $120 million in annualized net expense    savings, up from the previously projected $100 million.  <\/p>\n<p>    Analysts have a consensus moderate buy rating for ZBRA shares,    with a price target range of $300 to $320, indicating growth    potential.  <\/p>\n<p>      Source: rafapress \/ Shutterstock.com    <\/p>\n<p>    iRobot (NASDAQ:IRBT)    is known for its consumer-focused robotic products,    particularly home cleaning. The company continues to innovate    and expand its product offerings.  <\/p>\n<p>    In the first quarter of 2024, iRobots revenue was $150 million, down from $160.3    million in the same period the previous year. The companys    gross profit for Q1 2024 was $36.1 million, a slight decrease    from $36.7 million in Q1 2023. Despite these declines, iRobot    is making strategic moves to improve its financial position,    including significant cost reduction initiatives and    restructuring efforts.  <\/p>\n<p>    For 2024, iRobot expects revenue between $825 million and $865    million, with a GAAP net loss per share ranging from $3.13 to    $2.70. The company also projects an adjusted loss per share of    $3.73 to $3.30, indicating efforts to manage expenses and    improve margins.  <\/p>\n<p>    Looking forward, iRobot remains committed to innovation and    expanding its product offerings in the consumer robotics    market, particularly home cleaning solutions. The company    continues to develop new technologies and enhance existing    products.  <\/p>\n<p>      Source: T. Schneider \/ Shutterstock    <\/p>\n<p>    Aurora Innovation (NASDAQ:AUR)    provides hardware for autonomous trucks, and its self-detection    and response system offers a competitive advantage.  <\/p>\n<p>    Auroras fourth-quarter 2023 revenue reached $565,000, reflecting an    improvement in its pilot programs. However, the company    continues to report substantial operating expenses, totaling    $193 million for the quarter.  <\/p>\n<p>    For the first quarter of 2024, Auroras revenue increased to    $650,000, nearly doubling from the previous year. CEO Chris    Urmson highlighted the companys ongoing focus on enhancing the    Aurora Drivers autonomy performance and advancing its    commercial launch plans.  <\/p>\n<p>    Analysts have a mixed outlook on Aurora Innovation, with the    companys stock price target varying widely. Some analysts see potential in Auroras    long-term plans and technological capabilities, while others    remain cautious due to the autonomous driving sectors high    operating costs and competitive pressures.  <\/p>\n<p>    However, I think AUR could be one of those robotics stocks that    will deliver strong results for investors and should not be    underestimated.  <\/p>\n<p>    On the date of publication, Matthew Farley did not have    (either directly or indirectly) any positions in the securities    mentioned in this article. The opinions expressed are those of    the writer, subject to the InvestorPlace.com     Publishing Guidelines.  <\/p>\n<p>      Matthew started writing coverage of the financial markets      during the crypto boom of 2017 and was also a team member of      several fintech startups. He then started writing about      Australian and U.S. equities for various publications. His      work has appeared in MarketBeat, FXStreet, Cryptoslate,      Seeking Alpha, and the New Scientist magazine, among others.    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>View post:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/investorplace.com\/2024\/06\/the-7-best-robotics-stocks-to-buy-in-june-2024\/\" title=\"The 7 Best Robotics Stocks to Buy in June 2024 - InvestorPlace\">The 7 Best Robotics Stocks to Buy in June 2024 - InvestorPlace<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> As the broader indices like the Nasdaq continue their upward trajectory, now is a compelling time to consider investing in robotics stocks.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/robotics\/the-7-best-robotics-stocks-to-buy-in-june-2024-investorplace\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187746],"tags":[],"class_list":["post-1126070","post","type-post","status-publish","format-standard","hentry","category-robotics"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1126070"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1126070"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1126070\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1126070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1126070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1126070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}